Regulation of eosinophil adhesion by lysophosphatidylcholine via a non-store-operated Ca2+ channel

American Journal of Respiratory Cell and Molecular Biology

Volumn 36, Issue 5, 2007, Pages 585-593

  Zhu, Xiangdong ^a   Learoyd, Jonathan ^b   Butt, Sanober ^b   Zhu, Lilly ^b   Usatyuk, Peter V ^b   Natarajan, Viswanathan ^b   Munoz, Nilda M ^b   Leff, Alan R ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b NONE

Author keywords

Adhesion; Calcium; Eosinophils; Lysophosphatidylcholine

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; BETA2 INTEGRIN; BOVINE SERUM ALBUMIN; CALCIUM CHANNEL; CALCIUM ION; CD11B ANTIGEN; CD18 ANTIGEN; DIAZEPAM; G PROTEIN COUPLED RECEPTOR; INOSITOL DERIVATIVE; LYSOPHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPASE C; THROMBOCYTE ACTIVATING FACTOR;

ARTICLE; CALCIUM DEPLETION; CALCIUM TRANSPORT; CELL INFILTRATION; CONTROLLED STUDY; ENZYME ACTIVITY; EOSINOPHIL; HUMAN; IMMUNOMAGNETIC SEPARATION; LEUKOCYTE ADHERENCE; MOLECULAR MIMICRY; PROTEIN CONFORMATION; REGULATORY MECHANISM;

ANTIGENS, CD11B; CALCIUM CHANNELS; CELL ADHESION; EGTAZIC ACID; EOSINOPHILS; GENE EXPRESSION REGULATION; GTP-BINDING PROTEINS; HUMANS; LYSOPHOSPHATIDYLCHOLINES; MACROPHAGE-1 ANTIGEN; PHOSPHATIDYLETHANOLAMINES; PROTEIN CONFORMATION; RNA, MESSENGER; SERUM ALBUMIN, BOVINE; SIGNAL TRANSDUCTION; SOLUBILITY; TRANSIENT RECEPTOR POTENTIAL CHANNELS;

BOVINAE;

EID: 34247571856     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2006-0391OC     Document Type: Article

References (50)

1. Rothenberg ME, Hogan SP. The eosinophil. Annu Rev Immunol 2006; 24:147-174.
2. Weber C, Katayama J, Springer TA. Differential regulation of beta 1 and beta 2 integrin avidity by chemoattractants in eosinophils. Proc Natl Acad Sci USA 1996;93:10939-10944.
3. Fattah D, Page KR, Bezbaruah S, Priest RC, Morgan CM, Solari R. A rapid activation assay for human eosinophils based on adhesion to immobilized ICAM-1, VCAM-1 and IgG. Cytokine 1996;8:248-259.
4. Liu J, Munoz NM, Meliton AY, Zhu X, Lambertino AT, Xu C, Myo S, Myou S, Boetticher E, Johnson M, et al. Beta2-integrin adhesion caused by eotaxin but not IL-5 is blocked by PDE-4 inhibition and beta2-adrenoceptor activation in human eosinophils. Pulm Pharmacol Ther 2004;17:73-79.
5. Zhu X, Subbaraman R, Sano H, Jacobs B, Sano A, Boetticher E, Munoz NM, Leff AR. A surrogate method for assessment of beta(2)-integrin-dependent adhesion of human eosinophils to ICAM-1. J Immunol Methods 2000;240:157-164.
6. Lynch OT, Giembycz MA, Barnes PJ, Lindsay MA. Pharmacological comparison of LTB(4)-induced NADPH oxidase activation in adherent and non-adherent guinea-pig eosinophils. Br J Pharmacol 2001; 134:797-806.
7. Halin C, Scimone ML, Bonasio R, Gauguet JM. Mempel TR, Quackenbush E, Proia RL, Mandala S, von Andrian UH. The S1P-analog FTY720 differentially modulates T-cell homing via HEV: T-cell-expressed S1P1 amplifies integrin activation in peripheral lymph nodes but not in Peyer patches. Blood 2005;106:1314-1322.
8. Fieger CB, Huang MC, Van Brocklyn JR, Goetzl EJ. Type 1 sphingosine 1-phosphate G protein-coupled receptor signaling of lymphocyte functions requires sulfation of its extracellular amino-terminal tyrosines. FASEB J 2005;19:1926-1928.
9. Zheng Y, Kong Y, Goetzl EJ. Lysophosphatidic acid receptor-selective effects on Jurkat T cell migration through a Matrigel model basement membrane. J Immunol 2001;166:2317-2322.
10. Masiello LM, Fotos JS, Galileo DS, Karin NJ. Lysophosphatidic acid induces chemotaxis in MC3T3-E1 osteoblastic cells. Bone 2006; 39:72-82.
11. Matloubian M, Lo CG, Cinamon G, Lesneski MJ, Xu Y, Brinkmann V, Allende ML, Proia RL, Cyster JG. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 2004;427:355-360.
12. Prokazova NV, Zvezdina ND, Korotaeva AA. Effect of lysophosphatidylcholine on transmembrane signal transduction. Biochemistry (Mosc) 1998;63:31-37.
13. Jing Q, Xin SM, Zhang WB, Wang P, Qin YW, Pei G. Lysophosphatidylcholine activates p38 and p42/44 mitogen-activated protein kinases in monocytic THP-1 cells, but only p38 activation is involved in its stimulated chemotaxis. Circ Res 2000;87:52-59.
14. Lauber K, Bohn E, Krober SM, Xiao YJ, Blumenthal SG, Lindemann RK, Marini P, Wiedig C, Zobywalski A, Baksh S, et al. Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell 2003;113:717-730.
15. Kume N, Cybulsky MI, Gimbrone MA Jr. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest 1992;90:1138-1144.
16. Eizawa H, Yui Y, Inoue R, Kosuga K, Hattori R, Aoyama T, Sasayama S. Lysophosphatidylcholine inhibits endothelium-dependent hyperpolarization and N omega-nitro-L-arginine/indomethacin-resistant endothelium-dependent relaxation in the porcine coronary artery. Circulation 1995;92:3520-3526.
17. Takeshita S, Inoue N, Gao D, Rikitake Y, Kawashima S, Tawa R, Sakurai H, Yokoyama M. Lysophosphatidylcholine enhances superoxide anions production via endothelial NADH/NADPH oxidase. J Atheroscler Thromb 2000;7:238-246.
18. Silliman CC, Elzi DJ, Ambruso DR, Musters RJ, Hamiel C, Harbeck RJ, Paterson AJ, Bjornsen AJ, Wyman TH, Kelher M, et al. Lysophosphatidylcholines prime the NADPH oxidase and stimulate multiple neutrophil functions through changes in cytosolic calcium. J Leukoc Biol 2003;73:511-524.
19. Lin P, Welch EJ, Gao XP, Malik AB, Ye RD. Lysophosphatidylcholine modulates neutrophil oxidant production through elevation of cyclic AMP. J Immunol 2005;174:2981-2989.
20. Xu Y. Sphingosylphosphorylcholine and lysophosphatidylcholine: G protein-coupled receptors and receptor-mediated signal transduction. Biochim Biophys Acta 2002;1582:81-88.
21. Murphy AA, Santanam N, Morales AJ, Parthasarathy S. Lysophosphatidyl choline, a chemotactic factor for monocytes/T-lymphocytes is elevated in endometriosis. J Clin Endocrinol Metab 1998;83:2110-2113.
22. Okita M, Gaudette DC, Mills GB, Holub BJ. Elevated levels and altered fatty acid composition of plasma lysophosphatidylcholine(lysoPC) in ovarian cancer patients. Int J Cancer 1997;71:31-34.
23. Mehta D, Gupta S, Gaur SN, Gangal SV, Agrawal KP. Increased leukocyte phospholipase A2 activity and plasma lysophosphatidylcholine levels in asthma and rhinitis and their relationship to airway sensitivity to histamine. Am Rev Respir Dis 1990;142:157-161.
24. Chhabra SK, Khanduja A, Jain D. Decreased sodium-potassium and calcium adenosine triphosphatase activity in asthma: modulation by inhaled and oral corticosteroids. Indian J Chest Dis Allied Sci 1999; 41:15-26.
25. Van JJ, Jung JS, Lee JE, Lee J, Huh SO, Kim HS, Jung KC, Cho JY, Nam JS, Suh HW, et al. Therapeutic effects of lysophosphatidylcholine in experimental sepsis. Nat Med 2004;10:161-167.
26. Blondeau N, Lauritzen I, Widmann C, Lazdunski M, Heurteaux C. A potent protective role of lysophospholipids against global cerebral ischemia and glutamate excitotoxicity in neuronal cultures. J Cereb Blood Flow Metab 2002;22:821-834.
27. Zhu K, Baudhuin LM, Hong G, Williams FS, Cristina KL, Kabarowski JH, Witte ON, Xu Y. Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4. J Biol Chem 2001;276:41325-41335.
28. Kabarowski JH, Zhu K, Le LQ, Witte ON, Xu Y. Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A. Science 2001;293:702-705.
29. So I, Chae MR, Kim SJ, Lee SW. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces the change of calcium mobilization via TRPC ion channels in cultured human corporal smooth muscle cells. Int J Impot Res 2005;17:475-483.
30. Flemming PK, Dedman AM, Xu SZ, Li J, Zeng F, Naylor J, Benham CD, Bateson AN, Muraki K, Beech DJ. Sensing of lysophospholipids by TRPC5 calcium channel. J Biol Chem 2006;281:4977-4982.
31. Nishiyama O, Kume H, Kondo M, Ito Y, Ito M, Yamaki K. Role of lysophosphatidylcholine in eosinophil infiltration and resistance in airways. Clin Exp Pharmacol Physiol 2004;31:179-184.
32. Hansel TT, De Vries IJ, Iff T, Rilis S, Wandzilak M, Betz S, Blaser K, Walker C. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J Immunol Methods 1991;145:105-110.
33. Sano M, Leff AR, Myou S, Boetticher E, Meliton AY, Learoyd J, Lambertino AT, Munoz NM, Zhu X. Regulation of interleukin-5-induced beta2-integrin adhesion of human eosinophils by phosphoinositide 3-kinase. Am J Respir Cell Mol Biol 2005;33:65-70.
34. Sano A, Zhu X, Sano H, Munoz NM, Boetticher E, Leff AR. Regulation of eosinophil function by phosphatidylinositol-specific PLC and cytosolic PLA(2). Am J Physiol Lung Cell Mol Physiol 2001;281:L844-L851.
35. Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260:3440-3450.
36. Heiner I, Eisfeld J, Halaszovich CR, Wehage E, Jungling E, Zitt C, Luckhoff A. Expression profile of the transient receptor potential (TRP) family in neutrophil granulocytes: evidence for currents through long TRP channel 2 induced by ADP-ribose and NAD. Biochem J 2003;371:1045-1053.
37. Maingret F, Patel AJ, Lesage F, Lazdunski M, Honore E. Lysophospholipids open the two-pore domain mechano-gated K(+) channels TREK-1 and TRAAK. J Biol Chem 2000;275:10128-10133.
38. Smith RJ, Justen JM, McNah AR, Rosenbloom CL, Steele AN, Detmers PA, Anderson DC. Manning AM. U-73122: a potent inhibitor of human polymorphonuclear neutrophil adhesion on biological surfaces and adhesion-related effector functions. J Pharmacol Exp Ther 1996; 278:320-329.
39. Gillo B, Chorna I, Cohen H, Cook B, Manistersky I, Chorev M, Arnon A, Pollock JA, Selinger Z, Minke B. Coexpression of Drosophila TRP and TRP-like proteins in Xenopus oocytes reconstitutes capacitative Ca2+ entry. Proc Natl Acad Sci USA 1996;93:14146-14151.
40. Perozo E, Kloda A, Cortes DM, Martinac B. Physical principles underlying the transduction of bilayer deformation forces during mechanosensitive channel gating. Nat Struct Biol 2002;9:696-703.
41. Croset M, Brossard N, Poletle A, Lagarde M. Characterization of plasma unsaturated lysophosphatidylcholines in human and rat. Biochem J 2000;345:61-67.
42. Mochizuki M, Zigler JS Jr, Russell P, Gery I. Serum proteins neutralize the toxic effect of lysophosphatidyl choline. Curr Eye Res 1982;2:621-624.
43. Myou S, Zhu X, Boetticher E, Myo S, Meliton A, Lambertino A, Munoz NM, Leff AR. Blockade of focal clustering and active conformation in beta 2-integrin-mediated adhesion of eosinophils to intercellular adhesion molecule-1 caused by transduction of HIV TAT-dominant negative Ras. J Immunol 2002;169:2670-2676.
44. Yuan Y, Schoenwaelder SM, Salem HH, Jackson SP. The bioactive phospholipid, lysophosphatidylcholine, induces cellular effects via G-protein-dependent activation of adenylyl cyclase. J Biol Chem 1996; 271:27090-27098.
45. Bryant RE, Sutcliffe MC. The effect of 3′,5′-adenosine monophosphate on granulocyte adhesion. J Clin Invest 1974;54:1241-1244.
46. Alblas J, Ulfman L, Hordijk P, Koenderman L. Activation of Rhoa and ROCK are essential for detachment of migrating leukocytes. Mol Biol Cell 2001;12:2137-2145.
47. Zhu X, Jacobs B, Boetticher E, Myou S, Meliton A, Sano H, Lambertino AT, Munoz NM, Leff AR. IL-5-induced integrin adhesion of human eosinophils caused by ERK1/2-mediated activation of cPLA2. J Leukoc Biol 2002;72:1046-1053.
48. Zhu X, Munoz NM, Kim KP, Sano H, Cho W, Leff AR. Cytosolic phospholipase A2 activation is essential for beta 1 and beta 2 integrin-dependent adhesion of human eosinophils. J Immunol 1999;163:3423-3429.
49. Portman OW, Illingworth DR. Lysolecithin binding to human and squirrel monkey plasma and tissue components. Biochim Biophys Acta 1973;326:34-42.
50. Yuan Y, Jackson SP, Newnham HH, Mitchell CA, Salem HH. An essential role for lysophosphatidylcholine in the inhibition of platelet aggregation by secretory phospholipase A2. Blood 1995;86:4166-4174.